TCT-624 Impact of Post Dilation on the Acute and One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

Article2015

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

J. Ribamar Costa, Alexandre Abizaid, Antonio L. Bartorelli, Robert Whitbourn, Robert‐Jan van Geuns, Bernard Chevalier, Marcos Perin, Ashok Seth, Roberto Botelho, Patrick W. Serruys

EuroIntervention

Article2014

Abstract 11957: Impact of Post Dilatation on the One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

J. Ribamar Costa, Alexandre Abizaid, Antonio L. Bartorelli, Robert‐Jan van Geuns, Ashok Seth, Patrick W. Serruys

Circulation

Article2013

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

Takashi Muramatsu, Yoshinobu Onuma, Robert J. Van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai‐Fung Cheong, Robert Whitbourn, Antonio L. Bartorelli, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

Ariel Furer, Ori Ben‐Yehuda, Björn Redfors, Patrick W. Serruys, Runlin Gao, Takeshi Kimura, Dean J. Kereiakes, Stephen G. Ellis, Weiying Zhao, Minh-Thien Vu, Yoshinobu Onuma, Gregg W. Stone

Journal of the American College of Cardiology

Abstract

Discussion(0)

Related publications

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

Abstract 11957: Impact of Post Dilatation on the One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials